3 Big Pharmas Trying to Pop the Rebate Bubble

If you think the science driving the biopharmaceutical industry is wonky, try to follow a drug's paper trail once it leaves the manufacturer. In the U.S., wholesale distributors, retail pharmacies, hospitals, and physician practices are only the beginning. Undisclosed rebates that drugmakers concede to insurers and their intermediaries make following the money a complete mind-bender.